STAT+: Pharmalittle: Biogen hires Viehbacher as its CEO; new dengue vaccine rolled out amid safety concerns
Biogen named Christopher Viehbacher, who formerly ran Sanofi, as its new CEO, opening a new chapter for a biotech that has struggled since the disastrous launch of Aduhelm.
Top of the morning to you, and a fine one it is. Crystal clear blue skies and cool breezes are enveloping the
